Feb 10, 2021
Zika Virus for Childhood Cancer: Medicine’s Next Big Thing?
Neuroblastoma is the most common cancer in kids under age one. In two out of three cases, the cancer has already spread to the lymph...
Feb 10, 2021
New drug targets for childhood cancer neuroblastoma identified
The largest single cell study to date of the childhood cancer, neuroblastoma, has discovered that all neuroblastomas arise from a single...
Jan 26, 2021
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma
Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting...
Jan 7, 2021
Drug combination increases susceptibility to chemotherapy in cases of severe neuroblastoma
Researchers at the University of Gothenburg now suggest a possible cure for children with hard-to-treat forms of neuroblastoma using a...
Nov 30, 2020
New immunotherapy shows promise against rare childhood cancer
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results ...
Oct 14, 2020
CAR NKT cells offer a promising novel immunotherapy for solid tumors
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer properties in murine tumor models, have been ...
Oct 13, 2020
ICR to study fadraciclib to treat paediatric neuroblastoma
The Institute of Cancer Research (ICR) in the UK is set to conduct clinical trials of a new drug candidate, fadraciclib, to potentially...
Oct 8, 2020
Promising treatment for aggressive childhood cancer
A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by...
Aug 25, 2020
Blocking copper uptake in tumor cells may be clue to boosting immune system
Researchers have discovered that removing copper from the blood can destroy some of the deadliest cancers that are resistant to...
Jul 13, 2020
Despite treatment advances, ‘much to improve upon’ in high-risk neuroblastoma
As outcomes for high-risk neuroblastoma improve, refining treatment approaches in order to reduce late-term effects will be key,...